Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
SpineGuard announced today that it will launch two new products from its PediGuard platform at this week’s annual scientific meeting of the North American Spine Society (NASS), to be held in New Orleans on Oct. 9-12. The new products, XS Classic PediGuard and XS Curved PediGuard...
NuVasive to Exhibit Game-Changing New Products and Procedures at the 28th Annual North American Spine Society Annual MeetingOctober 7, 2013 8:33 am | by The Associated Press | News | Comments
NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will exhibit several game-changing new products and procedurally integrated solutions at the 28th Annual North American Spine Society (NASS) Annual Meeting, which will be held October 9-12, 2013, at the Ernest N. Morial Convention Center in New Orleans, La.
Trinity Orthopedics, a spine technology company, today announced the allowance of claims associated with patent 13/160,414 described as Percutaneous Transpedicular Access, Fusion, Discectomy and stabilization system and methods. This is an important step in completing the development of Trinity's Intraosseous Transpedicular Lumbar Interbody (ITLIF) procedure.
NuVasive Inc. introduced a new implant to be used with its XLIF spinal fusion procedure in the U.S., the XLIF Decade plate. The device is designed to provide surgeons with an option for a single-approach XLIF (eXtreme Lateral Interbody Fusion), NuVasive's alternative to traditional spinal fusion procedures.
BioTime today announced that it has initiated the development of two new products based on its HyStem hydrogel technology platform. The first of these new products is ReGlydeTM, a cross-linked thiol-modified hyaluronan hydrogel for the management and protection of tendon injuries following surgical repair of the digital flexor or extensor tendons of the hand.
NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the domestic launch of the XLIF Decade Plate. The XLIF Decade Plate is the Company's latest advancement in providing surgeon customers with an option for a single-approach XLIF® and fixation.
Royal Philips and Accenture today announced the creation of a proof-of-concept demonstration that uses a Google Glass head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions...
Royal Philips and Accenture today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions...
Invuity® Eigr™ Illumination Technology Showcased at International Congress for Joint Reconstruction Anterior Hip CourseOctober 2, 2013 3:57 pm | by Business Wire | News | Comments
Invuity, a leading developer of advanced visualization devices to optimize minimally invasive and minimal access surgeries, today announced that the 2 nd Annual Anterior Hip Course of the International Congress for Joint Reconstruction (ICJR) featured its Eigr™ Saber Waveguide with Yankauer in all cadaveric lab stations and in two live anterior hip arthroplasty surgeries.
Avenir Medical Inc., an innovator in developing intelligent instruments to improve joint replacement surgery, announced today that it has closed $3.3M of Series A financing. The round was led by MaRS Investment Accelerator Fund, Toronto, and included a syndicate of Angel Groups in Waterloo, Toronto, and Boston.
MAKO Surgical Corp. today announced that it has entered into an agreement with Pipeline Biomedical Holdings, Inc. to acquire substantially all of Pipeline's business dedicated to the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures.
FDA Grants Prestigious Award to Pediatric Medical Device Consortium Led by Children’s Hospital Los AngelesOctober 1, 2013 3:52 pm | by Business Wire | News | Comments
The U.S. Food and Drug Administration’s Office of Orphan Products Development has awarded a grant of up to $1.5 million over five years to the Southern California Center of Technology and Innovation in Pediatrics (CTIP), a consortium established by Children’s Hospital Los Angeles and the University of Southern California (USC) for the development of pediatric medical devices.
One day, I envision that there will be medical technology that can exceed the capabilities of the human body’s natural physiology. Should someone with such a device be prevented from playing professional sports due to the competitive advantage it provides?
Vertebral Technologies, Inc. (VTI) is pleased to announce the InterFuse Lateral (InterFuse L™) a modular lateral lumbar interbody fusion device has received 510(k) clearance from the FDA. The InterFuse L™ uses VTI’s patented modular insertion technique to provide a large lateral footprint through a significantly smaller lateral access channel.
Implants made of biocompatible material will help heal soldiers wounded in the battlefield and civilians as well through research at Rice University and The University of Texas Health Science Center at Houston. The implants hold open a space for a more permanent repair.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston (UTHealth).
A manufacturer of orthopedic implants needed to improve measurement and documentation proficiency of parts with literally hundreds of configurations. Air gaging from Mahr Federal was chosen because it could quickly and accurately measure precision tapers, along with being simpler and cheaper to engineer than any mechanical gages.
The Advanced Medical Technology Association (AdvaMed) today released a new study on pricing trends for implantable medical devices that shows average prices have declined significantly for major categories of implantable medical devices from 2007 through 2011.
A California state court ruled out a series of motions seeking to dismiss a lawsuit filed over bone proteins made by Stryker and Medtronic, ruling that federal law does not preempt the case from going forward. April Cabana sued the medical device companies for alleged off-label promotion of the bone growth products...
Shares of medical device makers rose Wednesday after Stryker Corp. agreed to buy robotic surgery system maker Mako Surgical for $1.41 billion. Stryker will pay $30 per share for Mako, an 86 percent premium based on the stock's latest closing price.
Stryker will spend $1.41 billion to acquire Mako Surgical and all of its robotic assisted surgery technology. The medical device maker will pay $30 per Mako share, an 86 percent premium to its $16.17 closing price Tuesday. The companies put the deal's value at about $1.65 billion.
A team from the University of Texas at Arlington has used mathematical modeling to develop a computer simulation they hope will one day improve the treatment of dangerous reactions to medical implants such as stents, catheters and artificial joints.
In the field of medical technology, wireless devices are seeing some of the most broad-reaching growth. This is due mostly in part to the wide range of applications that wireless medicine encompasses. Mobi Health News reports that the top ten areas wireless medicine has directly benefited include: Alzheimer’s, asthma, breast cancer, COPD, depression, diabetes, heart failure, hypertension, obesity, and sleep disorders.
The medical device and diagnostics market is set to grow at 4.5 percent per year (CAGR) between 2012 and 2018, totalling $455 billion in 2018, according to the newly-released EvaluateMedTech World Preview 2013, Outlook to 2018: The Future of Medtech report from market intelligence firm Evaluate Ltd.